Product Description
Presenting the antibiotic with a balanced coverage against gram positive and gram negative pathogens
Jexi
20
Cefpodoxime 200 mg. Tablets ghly active against both Gram +ve & Granve organisms Resistant to betalactamase degradation v 3 day therapy of Cefpodoxime 200 mg. BID is clinically effective as 8 days therapy of amoxycilliniclavulanic acid in acute maxillary sinusitis v Maintains serum concentration above MIC for longer time. v Attractive choice for empirical therapy
Jexim-O 200
y recovery with no difficulty
Also Available Jexi m-0
Cetpodoxime 50mg. Dry Syrup
Pharyngitis/Tonsilitis Chronic Bronchitis Uncomplicated UTI Acute Otitis Media Respiratory Tract Infections